Valsartan Price Trend

Valsartan Prices December 2023

In the USA, the prices of this pharma API were influenced by numerous factors during the last quarter of 2023. During the initial months, there was a surge in demand from end-consumers and limited inventories, which caused a price hike. However, by December, the prices declined, settling at 96995 USD/MT (US FDA) due to weakened demand from domestic and overseas markets.

In China, the product’s price during Q4FY2023 experienced stable trends that were influenced by several factors. Although there was stability in the market, compared to the same period last year, prices declined significantly. Also, there was a minute downfall in prices between the first and second half of Q4. Overall, the prices reached 95995 USD/MT (US FDA) by the end of the quarter.

The product’s price remained stable in Germany during the last quarter of 2023. This is attributed to stable economic conditions in the country and signs of improvement in the manufacturing sector. Also, the decline in consumer inflation led to an increase in purchasing power, which further contributed to the stable price trend. Finally, by the end of December, the market price reached 99595 USD/MT (US FDA).

Valsartan Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Valsartan Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of valsartan pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot price of valsartan at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of valsartan price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing valsartan price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Valsartan Market Analysis

The global valsartan market size reached US$ 5.1 Billion in 2023. By 2032, IMARC Group expects the market to reach US$ 7.7 Billion, at a projected CAGR of 4.70% during 2023-2032.

• The increasing number of cardiovascular diseases, such as hypertension and heart failure, is elevating the product’s demand due to its effectiveness in treating the diseases, which is one of the primary factors providing a considerable thrust to the market growth. As per the Centers for Disease Control and Prevention (CDC), in the United States, about 1 person dies every 33 seconds from cardiovascular disease. About 695,000 people in the country have died from heart disease in 2021—that's 1 in every 5 deaths.
• Moreover, the increasing product demand due to growing geriatric population predominantly in developed countries where cardiovascular diseases are more prevalent, is acting as another growth-inducing factor.
• The increased global awareness of early diagnosis and medical treatment of cardiovascular disorders has compelled the patients to select pharmacological treatments such as valsartan, which is creating a positive outlook for the market growth.
• In line with this, the surge in the number of unhealthy lifestyles, such as inactive livelihoods and unhealthy eating, has resulted in a marked and rising occurrence of CVD, thus fueling the market growth.
• Furthermore, technological advancements in drug development are spawning novel formulations and combinations of the product, improving its effectiveness and applicability in clinical practice, which is stimulating the market growth.
• Increased global health spending and greater access to health services in developing countries contribute to the consumption of more affordable and accessible variants of this pharma API.
• Additionally, promoter programs and other government-funded initiatives to promote cardiovascular health and sustainable healthcare are also expanding the market growth.
• The market is further expanding as pharmaceutical companies collaborate to manufacture and distribute other potent and sustainable product formulations and improve their competitive position, which is facilitating the market growth.
• Apart from this, burgeoning investments in research and development (R&D) activities have spurred innovation in the production and development of this drug, which is considerably supporting the market growth.

Valsartan News

The report covers the latest developments, updates, and trends impacting the global valsartan market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in valsartan production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the valsartan price trend.

Latest developments in the valsartan industry:

• In 2020, Novartis announced new data that show Entresto® (sacubitril/valsartan) can be initiated early & safely in hospitalized patients after an acute heart failure episode.
• In 2020, Pfizer Inc. announced it has completed the transaction to spin off its Upjohn Business and combine it with Mylan N.V. to form Viatris Inc.

Product Description

Valsartan is a widely prescribed medication belonging to the class of angiotensin II receptor blockers (ARBs), renowned for its efficacy in managing various cardiovascular conditions, particularly hypertension and heart failure. This pharmaceutical compound exerts its therapeutic effects by selectively blocking the action of angiotensin II on the angiotensin II type 1 (AT1) receptors, leading to vasodilation, reduced aldosterone secretion, and consequent lowering of blood pressure. Marketed under various brand names, this medication is available in oral formulations, including tablets and oral suspensions, catering to diverse patient needs and preferences.

As a cornerstone therapy for hypertension, this pharmaceutical compound plays a pivotal role in the comprehensive management of elevated blood pressure, either as a monotherapy or in combination with other antihypertensive agents. Its ability to effectively control blood pressure levels helps mitigate the risk of cardiovascular events, such as stroke and myocardial infarction, thereby enhancing patient outcomes and quality of life. Moreover, valsartan demonstrates favorable tolerability and safety profiles, making it suitable for long-term use in patients with chronic hypertension.

In addition to its antihypertensive properties, this compound is indicated for the treatment of heart failure, particularly in patients with reduced ejection fraction. By antagonizing the detrimental effects of angiotensin II on cardiac remodeling and neurohormonal activation, it helps alleviate symptoms of heart failure, improve exercise tolerance, and reduce the risk of hospitalization due to heart failure exacerbations. Its inclusion in heart failure management protocols underscores its significance as a cornerstone therapy in optimizing patient outcomes and reducing disease burden.

Regional Coverage

The report provides a detailed analysis of the valsartan market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the valsartan price trend.

Global Valsartan Price

The report offers a holistic view of the global valsartan pricing trends in the form of valsartan price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of valsartan but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.

The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed valsartan demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Valsartan Price

In the fourth quarter of 2023, the product’s pricing in Europe was affected by several key factors. In Germany, the largest market for this pharma API in the region, the prices remained stable throughout the quarter. The country's economy showed signs of gradual stability, with improved conditions in the manufacturing sector.

This analysis can be extended to include detailed valsartan price information for a comprehensive list of countries.

North America Valsartan Price

In the North America, the pricing of this drug in the fourth quarter of 2023 was influenced by several key factors, such as there was a moderate increase in prices in October and November due to a surge in demand from end-consumers and limited inventories in the market. This was further driven by an improvement in business activity and a moderation in inflation.

Specific valsartan historical data within the United States and Canada can also be provided.

Middle East and Africa Valsartan Price

The report explores the valsartan pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on valsartan prices for countries can also be provided.

Asia Pacific Valsartan Price

In the fourth quarter of 2023 (Q4), the product’s pricing in the APAC region was influenced by several factors, such as moderate supply levels and high demand from end-user industries. However, the overall market sentiment remained cautious due to sluggish exports and geopolitical complexities.

This valsartan price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Valsartan Price

The analysis of valsartan prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of valsartan pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting valsartan price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The valsartan price charts ensure our clients remain at the forefront of the industry.